SCHEMBL1492766

SCHEMBL1492766

CCOc1cccc(NC(=O)Nc2ccc(-c3ccnc(C)c3)cc2)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PSEN1 P49768 10/20 0.56
PSEN2 P49810 10/20 0.56
APH1B Q8WW43 10/20 0.56
NCSTN Q92542 10/20 0.56
APH1A Q96BI3 10/20 0.56
PSENEN Q9NZ42 10/20 0.56
PORCN Q9H237 2/20 0.56
NPC1 O15118 5/20 0.54
RAB9A P51151 5/20 0.54
MAPT P10636 4/20 0.54
SMN1; SMN2 Q16637 2/20 0.54
MEN1 O00255 2/20 0.54
KMT2A Q03164 2/20 0.54
MITF O75030 1/20 0.53
PAX8 Q06710 1/20 0.53
WNT3A P56704 1/20 0.53
GBA1 P04062 1/20 0.52
TP53 P04637 1/20 0.52
PKM P14618 1/20 0.51
POLB P06746 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1492873 0.91 PSEN1 (0.54) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL1492838 0.90 PORCN (0.55) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL27809666 0.89 PSEN1 (0.61) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL1492843 0.88 NPC1 (0.64) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL1492696 0.86 CNR1 (0.60) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL1492839 0.86 PORCN (0.61) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL1492858 0.84 CNR1 (0.65) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL1781477 0.84 PSEN1 (0.61) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL1492931 0.83 KMT2A (0.65) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL1492870 0.83 PSEN1 (0.67) PSEN1PSEN2APH1BNCSTNAPH1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102083794-A Urea compounds as gamma secretase modulators AMGEN INC 2011-06-01 CN claimed
US-20110118234-A1 Urea Compounds as Gamma Secretase Modulators AMGEN INC. 2011-05-19 US claimed
EP-2300427-A1 UREA COMPOUNDS AS GAMMA SECRETASE MODULATORS AMGEN INC. (US) 2011-03-30 EP claimed
WO-2009137404-A1 UREA COMPOUNDS AS GAMMA SECRETASE MODULATORS AMGEN INC. (US) 2009-11-12 WO claimed
US-20110118234-A1 Urea Compounds as Gamma Secretase Modulators AMGEN INC. 2011-05-19 US disclosed
US-20110118234-A1 Urea Compounds as Gamma Secretase Modulators AMGEN INC. 2011-05-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110118234-A1 Urea Compounds as Gamma Secretase Modulators BACE1, BACE2, PSEN1 PSEN1 3/4885PSEN2 4/4885APH1B 6/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.